Zoll Medical said results from the prospective registry and follow-up of Patients Using the Wearable Defibrillator (WEARIT-II) trial will be presented in a late-breaking clinical trial presentation at Heart Rhythm 2013. The session will be presented during the Heart Rhythm Society’s 34th Annual Scientific Sessions, Friday, May 10, 1:30-3 p.m., session number SP22.

InterValve Inc. announced that it has received 510(k) clearance to market the new V8 Aortic Valvuloplasty Balloon Catheter in the United States.

 

Acutus Medical Inc. (ACM) announced that it has performed its First-In-Man clinical study of its cardiac catheter to provide highest-quality real-time 3-D mapping of the human heart.

St. Jude Medical Inc. announced CE Mark approval and European launch of its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing options to deliver higher success rates, as evidenced by robust clinical data. Allure Quadra CRT-P brings the quadripolar lead technology to the pacemaker market. Quadripolar leads allow for increased implant efficiencies, which clinical data indicates can result in fewer surgical revisions. The Allure family of devices also offers heart failure (HF) diagnostics, including CorVue Impedance Monitoring, for improved patient management.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now